ObsEva SA
OBSVDelisted Mar 27, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001685316
ObsEva SA was delisted on Mar 27, 2023; its insiders filed their last Form 4 on Apr 11, 2023; 27 institutions reported holding it in 13F filings for Q4 2022, worth $1.89M in total; no superinvestor held it.
Holders of 5% or more of OBSV
Holders whose latest Schedule 13D or 13G filing reports 5% or more of ObsEva SA, largest stake first. The change is against the holder's previous filing.
No holder currently reports owning 5% or more of ObsEva SA on Schedule 13D or 13G.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
10 Schedule 13D and 13G filings on ObsEva SA, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Apr 17, 2023 | Loumaye Ernest | 13DOld format | – | – | – | SEC |
| Feb 14, 2023 | Loumaye Ernest | 13G/AOld format | – | – | – | SEC |
| Feb 6, 2023 | Sofinnova Venture Partners VIII, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 28, 2022 | Sofinnova Venture Partners VIII, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Loumaye Ernest | 13G/AOld format | – | – | – | SEC |
| Mar 4, 2021 | Sofinnova Venture Partners VIII, L.P. | 13D/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Loumaye Ernest | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Armistice Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 12, 2021 | OrbiMed Advisors LLC | 13G/AOld format | – | – | – | SEC |
| Feb 11, 2021 | Medicxi Growth I LP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell ObsEva SA shares.
No Form 144 notices for ObsEva SA are on file.